Published on: 2026-04-27
Source: Moscow Exchange – Московская Биржа –
An important disclaimer is at the bottom of this article.
On April 26, 2026, three years have passed since the date of the start of trading in the shares of PJSC “CGRM “Genetico” (GECO) on the Moscow Exchange. The company operates in the field of medical genetics, genetic research, as well as developing gene therapy drugs.
The company’s market capitalization has increased by 19% over three years and today amounts to more than 1.8 billion rubles.
The shareholder base since the beginning of stock trading has grown 10 times and currently counts over 30 thousand private and institutional investors.
Company shares are included in the third level of listing on the Moscow Exchange, included in the calculation base of the MOEX Innovation Index (MOEXINN), as well as in the market of innovations and investments of the Moscow Exchange (RII Sector) – stock market sector for high-tech companies with significant growth potential.
Shares of “Genetico” are available on the main, evening, and morning trading sessions of the Moscow Exchange stock market, as well as in the additional session of one day.
Congratulations to the company on the third anniversary of listing on the Moscow Exchange!
The Center for Genetics and Reproductive Medicine “Genetico” combines a medical-genetic center, a bioinformatics service, a quality control system, and one of the largest international-level laboratory and production complexes in Russia. Since 2012, the company has been conducting a wide range of genetic studies for diagnosis, prevention, and treatment of diseases. “Genetico” is part of the group of companies “Artgen Biotech” (ABIO), and is a resident of the Technopark Medtech Moscoww.
Moscow Exchange is the largest Russian exchange, the only multifunctional trading venue in Russia for stocks, bonds, derivatives, currency, money market instruments, and commodities. The “Moscow Exchange” group includes the central depository, as well as the clearing center, which performs the functions of the central counterparty on the market, enabling Moscow Exchange to provide clients with a full cycle of trading and post-trading services.
Please note; This information is unprocessed content directly obtained from the source of information. It represents an exact report of what the source asserts and does not necessarily reflect the position of MIL-OSI or its clients.